Hepatitis A without hepatic coma
Chapter 1:Certain infectious and parasitic diseases
ICD-10 B15.9 is a billable code used to indicate a diagnosis of hepatitis a without hepatic coma.
Hepatitis A is a viral infection that primarily affects the liver, caused by the Hepatitis A virus (HAV). It is characterized by the sudden onset of fever, malaise, nausea, abdominal discomfort, and jaundice. Unlike other forms of hepatitis, Hepatitis A does not lead to chronic liver disease and is typically self-limiting. The virus is transmitted primarily through the fecal-oral route, often via contaminated food or water. In most cases, the infection resolves within a few weeks, and patients recover completely without any long-term liver damage. Hepatitis A is particularly prevalent in areas with poor sanitation and hygiene practices. Chronic management is not required as the infection does not progress to a chronic state; however, patients should be educated on preventive measures, including vaccination and proper hygiene practices to avoid future infections. Complications are rare but can include acute liver failure, especially in individuals with pre-existing liver conditions. This code is used when the patient presents with Hepatitis A without any associated hepatic coma, indicating a less severe clinical presentation.
Detailed patient history, including exposure history and vaccination status.
Patients presenting with acute jaundice and gastrointestinal symptoms.
Ensure documentation reflects the acute nature of the infection and absence of chronicity.
Liver function tests, imaging studies if necessary, and follow-up care notes.
Patients with elevated liver enzymes and symptoms consistent with hepatitis.
Document any liver function tests and their results to support diagnosis.
Used to confirm diagnosis in symptomatic patients.
Document the reason for testing and results.
Infectious disease specialists should ensure proper interpretation of serology.
Common symptoms include fever, fatigue, nausea, abdominal pain, and jaundice. Symptoms typically appear 2-6 weeks after exposure.
